The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Full text access
Insuficiencia renal crónica (IRC) y anemia secundaria a mieloma múltiple (MM) en hemodiálisis (HD): efectos del tratamiento con eritropoyetina (r-EPO)
Visits
5856
A. Marigliano, O. Sánchez, J. M. Sánchez y A. Corvasi
This item has received
Article information
Full text is only available in PDF




